BioSpace News Archive

Pharm Country

How to Get an Internship in the Pharma Industry

Applying to your first pharma internship may feel overwhelming, but it doesn’t have to be. Discover how to find, prepare for and be successful in an internship in the pharma industry in our guide.

March 25, 2022
·
5 min read
·
Kaley Lefevre
Business

Roche and BMS Leveraging AI for Solid Tumor Treatment

Roche has partnered with BMS to utilize two digital pathology platforms that would advance research into solid tumor treatment options for patients.

March 25, 2022
·
2 min read
·
Vanessa Doctor, RN
French Study Contradicts Cancer Risk from Artificial Sweeteners

The study suggests that artificial sweeteners, which are readily available in coffee shops and used in diet soft drinks, increase the risks of breast cancer and obesity.

March 25, 2022
·
2 min read
·
Alex Keown
Drug Development

Novavax May Find COVID-19 Sweet Spot as a Booster

Novavax announced today that its protein-based Covid-19 vaccine, NVX-CoV2373, is included in two new clinical trials that will evaluate the vaccine as a potential Covid booster.

March 25, 2022
·
2 min read
·
Rosemary Scott
Sensorion Will Present at The H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference on March 30th, 2022

Sensorion is pleased to announce the participation of Sensorion’s CEO, Nawal Ouzren, in the H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference, an investor meeting being held on March 30th, 2022.

March 25, 2022
·
3 min read
Drug Development

Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody

Tiziana Life Sciences, a biotechnology company enabling breakthrough immunotherapies via novel routes of monoclonal antibody delivery, announced initiation of a Phase 1b clinical trial to evaluate orally administered enteric-coated capsules of foralumab in patients with mild-to-moderate Crohn’s Disease.

March 25, 2022
·
6 min read
Business

Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results

Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, reported its full year 2021 operating and financial results.

March 25, 2022
·
11 min read
Business

ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

ASLAN Pharmaceuticals announced financial results for the fourth quarter and full year ended December 31, 2021, and provided an update on recent corporate activities.

March 25, 2022
·
13 min read
Policy

Visby Medical Executes Contract Option with BARDA for $25.5M to Develop Rapid Flu-COVID PCR Test Designed for At-Home Use

Visby Medical™, a leading medical diagnostic company, announced that it has received an additional $25.5M in federal funding to develop and validate an at-home combination Flu-Covid test from the Biomedical Advanced Research and Development Authority.

March 25, 2022
·
3 min read
Drug Development

Sun Pharma Presents Phase 3 Data for WINLEVI® (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting

Sun Pharmaceutical Industries Limited today announced that the company’s U.S. subsidiary presented data from two pivotal Phase 3 clinical trials of WINLEVI (clascoterone) cream 1% for the topical treatment of acne vulgaris (acne).

March 25, 2022
·
9 min read